Engineering antibody-armed oncolytic viruses: design strategies, synergistic mechanisms, and clinical translation
Therapeutic antibodies are widely used in cancer biotherapy due to their target specificity, mediating tumor cell inhibition, angiogenesis suppression, and immune modulation. However, systemic administration often leads to off-target effects, as many a…